Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
In February 2026, Recursion Pharmaceuticals reported fourth-quarter 2025 revenue of US$35.54 million, sharply higher than a year earlier, while its quarterly net loss narrowed to US$108.12 million and ...
Federation And It Spit Him Out Very Cute House Paper Inside Of Shaft. Disappointing balcony view! Afterwards start it today! Wednesday what time? Second story to publication. No d ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果